NFE2L2 and chronic obstructive pulmonary disease: Independent work has demonstrated that hypermethylation of the NFE2L2 promoter contributes to reduced Nrf2 expression and impaired antioxidant defenses in COPD lungs, linking locus-specific methylation changes to disease-relevant redox dysfunction [23].